TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator

Immunity

Volumn 16, Issue 3, 2002, Pages 479-492

  Migone, Thi Sau ^a   Zhang, Jun ^a   Luo, Xia ^a   Zhuang, Li ^a   Chen, Cecil ^a   Hu, Bugen ^a   Hong, June S ^a   Perry, James W ^a   Chen, Su Fang ^a   Zhou, Joe X H ^a   Cho, Yun Hee ^a   Ullrich, Stephen ^a   Kanakaraj, Palanisamy ^a   Carrell, Jeffrey ^a   Boyd, Ernest ^a   Olsen, Henrik S ^a   Hu, Gang ^a   Pukac, Laurie ^a   Liu, Ding ^a   Ni, Jian ^a   Kim, Sunghee ^a   Gentz, Reiner ^a   Feng, Ping ^a   Moore, Paul A ^a   Ruben, Steve M ^a   Wei, Ping ^a   more..

^a GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DEATH DOMAIN CONTAINING RECEPTOR 3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1ALPHA; INTERLEUKIN 2; LIGAND; PROTEIN TL1A; RECEPTOR; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; T LYMPHOCYTE ACTIVATION;

EID: 18344385475     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(02)00283-2     Document Type: Article

References (28)

1. Apoptosis control by death and decoy receptors
2. Overexpression of M68/DcR3 in human gastrointestinal tract tumors independent of gene amplification and its location in a four-gene cluster
3. TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas(Apo-1/CD95)
4. Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95
5. In vivo inhibition of fas ligand-mediated killing by TR6, a fas ligand decoy receptor
6. The structure of human lymphotoxin (tumor necrosis factor beta) at 1.9 Å resolution
7. Studies on the interaction between TWEAK and the death receptor WSL-1/TRAMP (DR3)
8. A death-domain-containing receptor that mediates apoptosis
9. Continuous cultures of fused cells secreting antibody of predefined specificity
10. The TNF and TNF receptor superfamilies: Integrating mammalian biology
11. KB
12. Identification of a ligand for the death-domain-containing receptor Apo3
13. Effects of a dominant interfering mutant of FADD on signal transduction in activated T cells
14. Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer
15. TWEAK can induce cell death via endogenous TNF and TNF receptor 1
16. Lard: A new lymphoid-specific death domain containing receptor regulated by alternative pre-mRNA splicing
17. The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity
18. Characterization of a novel TNF-like ligand and recently described TNF ligand and TNF receptor superfamily genes and their constitutive and inducible expression in hematopoietic and non-hematopoietic cells
19. Target disruption of the mouse caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally
20. Kinetics of T cell activation in acute and chronic forms of murine graft-versus-host disease
21. DR3 regulates negative selection during thymocyte development
22. A novel TNF receptor family member binds TWEAK and is implicated in angiogenesis
23. A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis
24. TL1, a novel tumor necrosis factor-like cytokine, induces apoptosis in endothelial cells
25. VEGI, a novel cytokine of the tumor necrosis factor family, is an angiogenesis inhibitor that suppresses the growth of colon carcinomas in vivo
26. Inhibition of angiogenesis and breast cancer xenograft tumor growth by VEGI, a novel cytokine of the TNF superfamily
27. Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD.Mort/1
28. Modulation of T-cell responses to alloantigens by TR6/DcR3